India, Feb. 2 -- We need the world's drug regulators to come together to scrutinise clinical trial data - not take decisions one after another

Exactly one year later, the world is moving towards the next decisive phase in the fight against the novel coronavirus disease (COVID-19). Vaccines are now available and people are being inoculated - many rich countries have set targets for full immunisation by mid-year. With this done, they say, it can be back to business.

But for this to happen, we need hard introspection of our scientific and political leadership during this critical phase of recovery. Today, on the one hand, the virus is mutating and becoming more unpredictable and there is still too much that we do not know.

For instance, i...